Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning.
about
ESC working group cellular biology of the heart: position paper: improving the preclinical assessment of novel cardioprotective therapiesIschaemic conditioning: pitfalls on the path to clinical translationIschaemic conditioning and targeting reperfusion injury: a 30 year voyage of discoveryCardiovascular KATP channels and advanced agingRemote ischaemic conditioning in the context of type 2 diabetes and neuropathy: the case for repeat application as a novel therapy for lower extremity ulcerationThe Influence of Diabetes Mellitus in Myocardial Ischemic PreconditioningPharmacological postconditioning with atorvastatin calcium attenuates myocardial ischemia/reperfusion injury in diabetic rats by phosphorylating GSK3β.High carbohydrate and high fat diets protect the heart against ischaemia/reperfusion injuryAnti-inflammatory and cardioprotective effects of tadalafil in diabetic miceIschemic conditioning: the challenge of protecting the diabetic heart.Type 2 diabetes mellitus and myocardial ischemic preconditioning in symptomatic coronary artery disease patients.Differential response in levels of high-density lipoprotein cholesterol to one-year metformin treatment in prediabetic patients by race/ethnicity.PDE5 inhibitors as therapeutics for heart disease, diabetes and cancerRapid ventricular pacing-induced postconditioning attenuates reperfusion injury: effects on peroxynitrite, RISK and SAFE pathwaysInhibition of DPP-4 reduces acute mortality after myocardial infarction with restoration of autophagic response in type 2 diabetic rats.Involvement of Glycogen Synthase Kinase-3β and Oxidation Status in the Loss of Cardioprotection by Postconditioning in Chronic Diabetic Male Rats.Angiotensin-converting enzyme inhibition and food restriction in diabetic mice do not correct the increased sensitivity for ischemia-reperfusion injury.N-Acetylcysteine Restores Sevoflurane Postconditioning Cardioprotection against Myocardial Ischemia-Reperfusion Injury in Diabetic Rats.Angiotensin-converting enzyme inhibition and food restriction restore delayed preconditioning in diabetic mice.Diabetes, perioperative ischaemia and volatile anaesthetics: consequences of derangements in myocardial substrate metabolism.Durable Benefits of Cellular Postconditioning: Long-Term Effects of Allogeneic Cardiosphere-Derived Cells Infused After Reperfusion in Pigs with Acute Myocardial Infarction.Intermedin protects against myocardial ischemia-reperfusion injury in diabetic rats.Impact of multiple balloon inflations during primary percutaneous coronary intervention on infarct size and long-term clinical outcomes in ST-segment elevation myocardial infarction: real-world postconditioning.Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart.Metformin therapy in diabetes: the role of cardioprotection.Cardiomyocyte changes in the metabolic syndrome and implications for endogeneous protective strategies.Hexokinases and cardioprotection.Contribution of apoptosis in myocardial reperfusion injury and loss of cardioprotection in diabetes mellitus.Remote ischaemic conditioning and remodelling following myocardial infarction: current evidence and future perspectives.Oxidative stress-mediated reperfusion injury: mechanism and therapies.Delta Opioid Receptors and Cardioprotection.Recent advances in magnetoliposome for heart drug delivery.Insights for Oxidative Stress and mTOR Signaling in Myocardial Ischemia/Reperfusion Injury under Diabetes.Ischemic postconditioning: mechanisms, comorbidities, and clinical application.Improved resistance to ischemia and reperfusion, but impaired protection by ischemic preconditioning in patients with type 1 diabetes mellitus: a pilot study.Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in ratsEffects of Nitrate Intake on Myocardial Ischemia-Reperfusion Injury in Diabetic Rats.Cardioprotective efficacy depends critically on pharmacological dose, duration of ischaemia, health status of animals and choice of anaesthetic regimen: a case study with folic acid.Hexokinase cellular trafficking in ischemia-reperfusion and ischemic preconditioning is altered in type I diabetic heart.Myocyte membrane and microdomain modifications in diabetes: determinants of ischemic tolerance and cardioprotection.
P2860
Q24289195-1F86B4A4-F437-448C-8FC6-D4C8AD4022A3Q27000466-7B6CD4FA-9F94-4EFA-8497-9FEE9D842814Q28072918-510AD877-4432-4A05-BF00-6ECD1B4966B1Q28076393-82E6EB74-60CC-45E9-9E4C-CD9A8CD3F64BQ28078462-78DA5D5C-A507-4829-9B30-F7565C4F9BA9Q28080349-237C3B69-8529-4CDD-ADC8-EC6D89DB423EQ33846404-B94C4109-0F7E-4F77-8EB3-E9A9903DAE1FQ33948647-95691EBB-CF4C-4A9C-97AC-5E328C6C4B66Q34428464-3CF3450D-1E69-433F-91AB-8AACB6CF96FEQ34457775-4836701E-FBF4-490C-B2FE-1BB1ABAE7127Q35672947-229F6F18-F588-4897-BCEA-D419C29347B0Q35736638-EC207430-14A0-41DE-90CE-C7ED7F33600CQ35827798-51DC5008-3348-4953-BB67-AC456D4A58BBQ35865412-BA5EBFC4-359A-49E6-B8B0-376C76966CBAQ35936441-80810924-FD78-44D4-9031-9E655DB0CF87Q36196031-741DFAF6-E0E6-4119-9543-B71F05811E2AQ36239967-8C4E23C4-7AA7-461E-ADD2-4EF0050EF53DQ36405244-A57B7A77-4A2A-4C0D-B725-814454D6578DQ36688050-3AF4CF62-B792-4704-9CDB-C9238691B57AQ36689230-3A5ECA38-836A-4A34-A5F3-4BF15D37D022Q36714104-AFE9EDC0-CD8E-4D65-BC5C-DA9D9F26581FQ36988132-65A8D592-0004-4A7B-AAE3-D54DE2E91374Q37633996-EC98BBB2-EF40-44D0-AC02-EDAAEAC593EDQ37686277-DACA4151-D639-4371-8F14-620DADB983BBQ38083008-A8A9D9A8-4EB6-4322-AE32-30530814FCD5Q38191658-804BE5E7-4642-49E7-9DC0-3E1F919D7D75Q38255143-9CB8F093-15E8-4216-A09F-B7078BCAF196Q38366174-0D8A994E-BE51-4A0B-AD6D-CB79A5207DEFQ38833919-4460793D-8439-45C3-994C-F3BF11A4A92EQ38922662-7902A804-39AC-40FD-BC20-2788D304D0ACQ39151222-FC296D8B-5BD9-47FB-8CD9-9181FC58D4DCQ39168374-E4D56DA8-1164-48D3-87EC-AC0587D2B41AQ39180915-30786CCB-FBEF-4DBD-8C01-3A8E8B533607Q39232678-E3173749-0DF8-4B07-B954-4565735D54EDQ41741312-02067A0D-61C9-4CC1-BBD3-195F1E259108Q41873186-1D0DB97A-151D-4ABA-964C-1F759DF9995EQ42371275-AF89DBDC-1AEC-4F82-93CF-417996B5724FQ42599755-81E08A07-829B-45F5-84C6-67AEC9A0EC54Q45065649-E1433583-5A2D-427E-92C8-EF640C3D63C4Q46034115-56AB4AC8-9E0D-442F-AEE2-1CDF67C64037
P2860
Effects of diabetes on myocardial infarct size and cardioprotection by preconditioning and postconditioning.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Effects of diabetes on myocard ...... itioning and postconditioning.
@ast
Effects of diabetes on myocard ...... itioning and postconditioning.
@en
type
label
Effects of diabetes on myocard ...... itioning and postconditioning.
@ast
Effects of diabetes on myocard ...... itioning and postconditioning.
@en
prefLabel
Effects of diabetes on myocard ...... itioning and postconditioning.
@ast
Effects of diabetes on myocard ...... itioning and postconditioning.
@en
P2093
P2860
P921
P356
P1476
Effects of diabetes on myocard ...... itioning and postconditioning.
@en
P2093
Daisuke Sunaga
Takahito Itoh
Takayuki Miki
Tetsuji Miura
P2860
P2888
P356
10.1186/1475-2840-11-67
P407
P5008
P577
2012-06-13T00:00:00Z
P5875
P6179
1018085902